Combination therapy with interleukin-2 and α-interferon for the treatment of patients with cervical condilomatous;ASSOCIAZIONE DI INTERLEUCHINA-2 ED INTERFERONE-α NEL TRATTAMENTO DELLA CONDILOMATOSI DELLA CERVICE UTERINA

Minerva Ginecologica

Volumn 48, Issue 3, 1996, Pages 111-113

  Zarcone, R ^a   Bellini, P ^a,b   Cardone, G ^a   Barletta, E ^a   Vicinanza, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Cervix condilomata; Interferon; Interleukin

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA; DRUG THERAPY; EOSINOPHIL; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY CELL; INTRALESIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOBLAST; LYMPHOCYTE; LYMPHOCYTE COUNT; TREATMENT OUTCOME; UTERINE CERVIX; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REMISSION INDUCTION; UTERINE CERVICAL DISEASES; VAGINAL SMEARS;

EID: 0029920315     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Breatnach SM, Katz SI. Cell mediated immunity in cutaneous disease Human Pathol 1986,17:161-7.
2. Evans CH, Flugelman AA, Di Paolo JA. Cytochine modulation of immune defences in cervical cancer. Oncology 1993;50 4:245-51.
3. Dianzani F. Il sistema Interferon. Sedac edizioni, 1990.
4. Siegel JP. Effects of Interferon on the activation of human T-hmphocyte Cel Immunol 1986,11 2 461-72.
5. Brunda MJ, Bellantoni D, Sulich V In vivo antitumor activity of combinations of interferon-a and interleukin-2 in a murine model Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells Int J Cancer 1987;40.365-71
6. Smith KA Interleukin-2. Le Scienze, 1990;261:24-31.
7. Gross G, Stegner HE. Genital Papillomavirus Infection Berlin: Springer, 1990
8. Gissmann L, de Villiers EM et al Analysis of human worts (condylomata acuminata) and other genitale tumors for human papillomavirus type 6-DNA. Int J Cancer 1982;29:143-6
9. Radhakrishna Pillai M, Prabha B et al Interleukin-2 and alpha-IFN induced in vitro modulation of spontaneuous cells mediated cytotoxicity in patients with cancer of the uterine cervix undergoing radiotherapy Acta Oncol 1989,28.39-44.
10. Macciò A, Melis GB, Mantovani G et al. Interleuchina 2r ed IFN alfa naturale leucocitario nelal condilomatosi assocsata a CIN. Atti Con Dormus De Maria, 13-19/9/1992
11. Rosemberg SA et al Combination therapy with interleukin-2r and α-IFN for treatment of patients with advanced cancer J Clin Oncol 1989;7(2):1863-74.
12. Zarcone R, Cardone G et al. Schemi terapeutici per il trattamento delle infezioni da HPV mediante l'uso di α-IFN per via sistemtca Minerva Ginecol 1992.44:193-5.
13. Zarcone R et al. Schemi terapeutici per il trattamento delle infezioni da HPV mediante l'uso di IFN-α per via topica. Minerva Ginecol 1992;44:189.
14. Zarcone R, Bellini P, Cardone G et al. Treatment of cervix condylomata with alpha-IFN leucocytar Clin Exp Ostet Gynecol In Press.